ArticleDie Naturwissenschaften2026
Potent anticancer activity of phenolic-enriched extracts from endemic plants supported by in vitro pharmacological analyses and in silico molecular docking.
Article in Die Naturwissenschaften, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanisms and Therapeutic Targets of Botanicals Derived from Asteraceae Plant Species.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the present study, methanol and aqueous extracts obtained from two endemic plants, Dianthus elegans var. actinopetalus (Fenzl) Reeve and Linum ciliatum Hayek, were investigated for their phenolic composition, antioxidant activities, cytotoxic potential, and supported by in silico molecular docking analysis. High-performance liquid chromatography revealed distinct phenolic acid and flavonoid profiles among the extracts, with the methanol extract of L. ciliatum (LME) exhibiting the richest phenolic content. Consistently, LME showed the highest total phenol (314.69 µg/mg) and total flavonoid (91.61 µg/mg) levels. Antioxidant capacity was evaluated using DPPH radical scavenging and metal chelation assays, in which LME demonstrated the strongest activity with the lowest IC₅₀ values (45.49 and 40.10 µg/mL, respectively), highlighting the influence of extraction solvent on bioactivity. Cytotoxic effects were assessed on Mahlavu and MCF-7 cell lines at 24, 48, and 72 h. Both methanol and aqueous extracts of L. ciliatum exhibited time-dependent cytotoxicity, with LME showing a remarkably low IC₅₀ value of 0.66 µg/mL on MCF-7 cells after 72 h. To gain insight into the molecular basis of the observed cytotoxic effects, in silico molecular docking was performed using the anti-apoptotic Bcl-2 protein as a target. The major phenolic compounds, particularly chlorogenic acid, quercetin, and naringenin, exhibited strong binding affinities toward Bcl-2, suggesting a possible involvement of apoptosis-related pathways. In contrast, none of the extracts showed antibacterial activity against the tested Gram-positive or Gram-negative bacteria. Overall, the findings indicate that methanol extraction is more effective for obtaining phenolic-rich extracts with pronounced antioxidant and anticancer potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.